CivaTech Oncology Garners $1,202,201 New Round

  • Feed Type
  • Date
    7/29/2014
  • Company Name
    CivaTech Oncology
  • Mailing Address
    104 T.W. Alexander Drive Building 4 Research Triangle Park, NC 27709 USA
  • Company Description
    The mission of the company is to create a product that will be the standard of care for low-dose-rate (LDR) brachytherapy. The first focus of the Company will be on prostate cancer. Civatech Oncology seeks to provide physicians and patients with a superior brachytherapy treatment option for battling cancer.
  • Website
    http://www.civatechoncology.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,202,201
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy